Prueba de espectro de anticuerpos covídicos largos (AMVAIS)

The Attomarker Multi-Variant Antibody Immunity Spectrum (AMVAIS) test helps us to get one step closer to precision medicine in Long Covid treatments – in this case especially in the area of antiviral therapy. Antibodies are a vital part of our immune systems. When analysing patient antibody responses across a range of COVID variants, it is evident that individual immunity and hence how vulnerable a person is, noticeably varies. In case of the AMVAIS test these individual responses are called immunity endotypes. 

Esperamos devolverle sus resultados en un plazo de 2 semanas tras la recepción de la muestra. Recibirá: un espectro de anticuerpos y un informe de laboratorio.

Prof Andrew Shaw sobre el perfil inmunitario de anticuerpos en Long Covid (Fuente del vídeo: LCCWYCD)

 *Service  provided by Attomarker